Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patients
Background: Diabetes mellitus (DM) seems to be conveying increased risk in Coronavirus disease-2019 (COVID-19). We aimed to evaluate the effect of glycemic control on the risk of prevalence and mortality in diabetic COVID-19 patients. Materials and Methods: In this retrospective observational stud...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Journal of Diabetology |
| Subjects: | |
| Online Access: | http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2023;volume=14;issue=1;spage=41;epage=47;aulast=Torun |
| _version_ | 1827894839348297728 |
|---|---|
| author | Elif Torun Parmaksız Ergün Parmaksız |
| author_facet | Elif Torun Parmaksız Ergün Parmaksız |
| author_sort | Elif Torun Parmaksız |
| collection | DOAJ |
| description | Background: Diabetes mellitus (DM) seems to be conveying increased risk in Coronavirus disease-2019 (COVID-19). We aimed to evaluate the effect of glycemic control on the risk of prevalence and mortality in diabetic COVID-19 patients. Materials and Methods: In this retrospective observational study, the data from diabetic patients admitted to our hospital with the diagnosis of COVID-19 between March 2020 and March 2021 were reviewed. The demographic, clinical, laboratory, and radiological data, and the course and outcomes were recorded. Results: The records of 352 diabetic patients were compared to 333 non-diabetic controls. The mean age of 184 male and 168 female patients was 63.7±13.0 (30–91). The length of hospital stay, rate of Intensive care unit (ICU) admission, and mortality were higher in the diabetic population compared to the non-diabetic counterparts. ICU admission and mortality rates were significantly higher in the group with HbA1c higher than 7%. The rate of ICU admission and mortality was significantly higher in participants with elevated HbA1cConclusions: Uncontrolled DM is among detrimental comorbidities contributing to the severity of SARS-CoV-2 infection and good control of serum glucose levels will improve prognosis in COVID-19. The diabetic population with poor glycemic control succumbed more to COVID-19. |
| first_indexed | 2024-03-12T22:13:15Z |
| format | Article |
| id | doaj.art-c057ed35ad354db08ada89bac18258e7 |
| institution | Directory Open Access Journal |
| issn | 2078-7685 |
| language | English |
| last_indexed | 2024-03-12T22:13:15Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Diabetology |
| spelling | doaj.art-c057ed35ad354db08ada89bac18258e72023-07-23T11:29:20ZengWolters Kluwer Medknow PublicationsJournal of Diabetology2078-76852023-01-01141414710.4103/jod.jod_120_22Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patientsElif Torun ParmaksızErgün ParmaksızBackground: Diabetes mellitus (DM) seems to be conveying increased risk in Coronavirus disease-2019 (COVID-19). We aimed to evaluate the effect of glycemic control on the risk of prevalence and mortality in diabetic COVID-19 patients. Materials and Methods: In this retrospective observational study, the data from diabetic patients admitted to our hospital with the diagnosis of COVID-19 between March 2020 and March 2021 were reviewed. The demographic, clinical, laboratory, and radiological data, and the course and outcomes were recorded. Results: The records of 352 diabetic patients were compared to 333 non-diabetic controls. The mean age of 184 male and 168 female patients was 63.7±13.0 (30–91). The length of hospital stay, rate of Intensive care unit (ICU) admission, and mortality were higher in the diabetic population compared to the non-diabetic counterparts. ICU admission and mortality rates were significantly higher in the group with HbA1c higher than 7%. The rate of ICU admission and mortality was significantly higher in participants with elevated HbA1cConclusions: Uncontrolled DM is among detrimental comorbidities contributing to the severity of SARS-CoV-2 infection and good control of serum glucose levels will improve prognosis in COVID-19. The diabetic population with poor glycemic control succumbed more to COVID-19.http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2023;volume=14;issue=1;spage=41;epage=47;aulast=Toruncoronavirus disease-2019diabetes mellitusglycolyzed hemoglobin |
| spellingShingle | Elif Torun Parmaksız Ergün Parmaksız Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patients Journal of Diabetology coronavirus disease-2019 diabetes mellitus glycolyzed hemoglobin |
| title | Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patients |
| title_full | Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patients |
| title_fullStr | Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patients |
| title_full_unstemmed | Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patients |
| title_short | Glycolyzed hemoglobin as a poor prognostic factor in diabetic COVID-19 patients |
| title_sort | glycolyzed hemoglobin as a poor prognostic factor in diabetic covid 19 patients |
| topic | coronavirus disease-2019 diabetes mellitus glycolyzed hemoglobin |
| url | http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2023;volume=14;issue=1;spage=41;epage=47;aulast=Torun |
| work_keys_str_mv | AT eliftorunparmaksız glycolyzedhemoglobinasapoorprognosticfactorindiabeticcovid19patients AT ergunparmaksız glycolyzedhemoglobinasapoorprognosticfactorindiabeticcovid19patients |